-
Loading metrics
Inhibition of AKT with the Orally Active Allosteric AKT Inhibitor, MK-2206, Sensitizes Endometrial Cancer Cells to Progestin
- Alok Pant,
- Irene I. Lee,
- Zhenxiao Lu,
- Bo R. Rueda,
- Julian Schink,
- J. Julie Kim
x
- Published: July 24, 2012
- https://doi.org/10.1371/journal.pone.0041593